The BSD-2000 provides deep regional therapeutic hyperthermia to solid tumors (primarily for cervical cancer) by applying radiofrequency (RF) energy at the frequency range of 75 to 120 MHz.
Hosted on MSN5mon
New Heat-Based Cancer Therapy May Lower Chemotherapy Dosages: Studyan inhibitor of Heat Shock Protein 90 (HSP90), with magnetic hyperthermia-based cancer therapy (MHCT) can enhance the effectiveness of heat-based cancer treatments. This combination approach could ...
The BSD-2000/3D provides targeted deep regional therapeutic hyperthermia to solid tumors by applying radiofrequency (RF) energy. The BSD-2000/3D delivers energy to a patient using a power source ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback